Leukaemoid monocytosis in M4 AML following chemotherapy and G-CSF

Clinical and Laboratory Haematology

Volumn 20, Issue 1, 1998, Pages 49-51

  Ranaghan, L ^a   Drake, M ^a   Humphreys, M W ^a   Morris, T C M ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

Author keywords

G CSF; Monocytosis; Myeloid leukaemia

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ARTICLE; CANCER CHEMOTHERAPY; CASE REPORT; DRUG WITHDRAWAL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMOID REACTION; MALE; MONOCYTOSIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

AGED; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LEUKEMIA, MYELOMONOCYTIC, ACUTE; LEUKEMOID REACTION; LEUKOCYTOSIS; MALE; MONOCYTES;

EID: 0031893651     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1998.00083.x     Document Type: Article

References (13)

1. Arici M., Haznedaroglu I., Erman M. & Ozcebe O. (1996) Leukoerythroblastosis following the use of G-CSF. American Journal of Hematology 52, 123-124.
2. Bonilla M.A., Dale D., Zeidler C. et al. (1994) Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias. British Journal of Haematology 88, 723-730.
3. Dombret H., Chastang C., Fenaux P. et al. (1995) A controlled study of recombinant human granulocyte colony-stimulating factor in elderly patients after treatment for acute myeloid leukaemia. New England Journal of Medicine 332, 1678-1683.
4. Geller R.B. (1996) Use of cytokines in the treatment of acute myeloid leukaemia: a critical review. Journal of Clinical Oncology 14, 1371-1382.
5. Harousseau J.L. & Depei W.U. (1995) The use of GM-CSF and G-CSF in the treatment of acute leukaemias. Leukaemia and Lymphoma 18, 405-412.
6. Heil G., Hoelzer D., Sanz M.A. et al. (1995) Results of a randomised, double-blind placebo controlled phase in study of tilgrastim in remission induction and early consolidation therapy for adults with de-novo acute myeloid leukaemia. Blood 86(10) (Suppl. 1) 1053.
7. Imashuku S., Hibi S., Kataoka-Morimoto Y. et al. (1995) Myelodysplasia and acute myeloid leukaemia in cases of aplastic anaemia and congenital neutropenia following G-CSF administration. British Journal of Haematology 89, 188-190.
8. Kalra R., Dale D., Freedman M. et al. (1995) Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia. Blood 86, 4579-4586.
9. Kojima S., Tsuchida M. & Matsuyama T. (1992) Myelodysplasia and leukaemia after treatment of aplastic anaemia with G-CSF. New England Journal of Medicine 326, 1294-1295.
10. Reale M.A., Yen Y., Strair R.K., Flynn S.D. & Cooper D.L., (1995) Pseudoleukaemia after granulocyte colony-stimulating factor therapy. Southern Medical Journal 88, 462-464.
11. Reykdal S., Sham R., Phatak P. and Kouides P. (1995) Pseudoleukaemia following the use of C-CSF. American Journal of Hematology 49, 258-259.
12. Takamatsu H., Nakao S., Ohtake S. et al. (1993) Granulocyte colony-stimulating factor-dependent leukaemia cell proliferation in vivo in acute promyelocytic leukaemia. Blood 81, 3485-3486.
13. Tohyama K., Ueda T., Yoshida & Nakamura T. (1994) Altered response of purified blast cells from the myelodysplastic syndromes to colony-stimulating factors m vitro: compared with normal blast cells. Experimental Haematology 22, 539-545.